Optimizing Outcomes with Myeloablative Conditioning in Older Patients: Efficacy and Safety of Precision Engineered Orca-T in Patients > 55 Years Old with Hematologic Malignancies Oliai, C. H., Pantin, J. M., Hoeg, R. T., Muffly, L. S., Patel, S. S., Gandhi, A., Lowsky, R., Salhotra, A., Dholaria, B., Waller, E. K., Srour, S. A., Pavlova, A., Fernhoff, N. B., Agodoa, I., McClellan, J., Abedi, M., Negrin, R. S., Meyer, E. H. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-186749

View details for Web of Science ID 001159306700231